Small-Cap Stocks Surge with Biotech and Tech Rallies
By ATTN Desk · Editorial oversight: Sean Han
Daily Market Recap – July 14, 2025
Introduction
On July 14, 2025, a broad swath of small- and micro-cap equities staged outsized rallies, with several names surging well over 100% and trading volumes spiking into the tens—or even hundreds—of millions. Biotech and technology-related issues led the way, driving market breadth firmly into positive territory. Below is a summary table of key movers, followed by an analysis of overall trends and notable standouts.
Key Movers Table
| Ticker | ATTN Price | Current Price | Volume | Price Change % |
|---|---|---|---|---|
| DARE | 1.0346 | 3.1487 | 45,947,646 | 204.30% |
| SONN | 3.6675 | 9.1000 | 26,813,937 | 148.07% |
| SQFT | 4.4095 | 11.0000 | 28,396,102 | 149.46% |
| CLIK | 0.2757 | 0.3950 | 18,292,327 | 43.24% |
| YHC | 2.6154 | 4.2800 | 22,815,719 | 63.73% |
| SDST | 0.3374 | 0.4880 | 209,507,392 | 44.65% |
| MGRM | 4.8376 | 5.6308 | 9,694,197 | 16.44% |
| OP | 1.2267 | 1.7800 | 19,109,510 | 45.10% |
| WINT | 0.5549 | 0.7900 | 26,256,723 | 42.47% |
| EDHL | 0.5361 | 0.8398 | 11,151,336 | 56.72% |
| VSEE | 0.8982 | 1.2100 | 10,826,751 | 34.70% |
| PMN | 0.1663 | 0.4832 | 63,012,694 | 190.70% |
| ABVE | 1.6095 | 2.4302 | 18,374,268 | 51.04% |
| NEGG | 21.9690 | 34.0000 | 1,403,957 | 54.82% |
| RYET | 0.1321 | 1.6897 | 7,325,978 | 1,180.00% |
| TROO | 0.2645 | 1.0500 | 61,946,702 | 296.97% |
| BGL | 13.8615 | 25.8300 | 859,866 | 86.34% |
| OCC | 4.0189 | 5.8600 | 1,077,162 | 45.82% |
| SRFM | 4.6548 | 7.0391 | 12,516,577 | 51.29% |
Note: ATTN Price represents the approximate opening price, calculated from the reported change percentage and current price.
Biotech Surge by CDC
Market Trends and Analysis
The session was defined by sweeping gains across speculative sectors, particularly biotech and disruptive technology plays. Key observations:
- Widespread rallies: Nearly every stock in today’s table finished higher, with 11 out of 19 issues more than doubling from opening levels.
- Extraordinary volume: SDST led all names with over 209 million shares traded, followed by TROO (61.9 M) and PMN (63.0 M). Elevated turnover underscored strong investor interest in high-beta names.
- Biotech momentum: RYET’s 1,180% leap and PMN’s 190.7% gain spotlight continued appetite for early-stage biotech catalysts. Both stocks advanced on news flow around clinical developments.
- Technology and real estate: SQFT and SONN each climbed roughly 150% as market participants rotated into contrarian tech and REIT strategies, respectively.
Significant Price Movements
- RYET soared 1,180% on 7.3 million shares, marking the most dramatic one-day increase in the group.
- TROO jumped 296.97% on nearly 62 million shares, remaining among the volume leaders.
- DARE rose 204.30% on 45.9 million shares as investor focus intensified on its clinical-stage pipeline.
- PMN added 190.70% on 63.0 million shares following updates on its Alzheimer’s trial funding.
- SONN and SQFT each rallied around 149–148% on volumes above 26 million.
TL;DR
- Small-cap names rallied broadly, with biotech and tech leading the charge.
- RYET (+1,180%), TROO (+297%), DARE (+204%) and PMN (+191%) posted the largest gains.
- SDST (209 M), PMN (63 M) and TROO (62 M) topped the volume leaderboard.
- Investor interest skewed toward high-beta sectors, driving significant price and volume spikes.